ERYTECH PHARMA
18Patents
18Active
18Granted
52Portfolio score
Filing activity: Aug 4, 2005 → Jun 30, 2023 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9364504B2 | Compostition and therapeutic anti-tumour vaccine | Human Necessities | 34 | Active |
| US8617840B2 | Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes | Human Necessities | 22 | Active |
| US9950049B2 | Composition and therapeutic anti-tumour vaccine | Human Necessities | 21 | Active |
| US8852880B2 | Test for predicting neutralization of asparaginase activity | Physics | 15 | Active |
| US9125876B2 | Erythrocytes containing arginine deiminase | Emerging Cross-Sectional Technologies | 15 | Active |
| US8974802B2 | Medicament for the treatment of cancer of the pancreas | Emerging Cross-Sectional Technologies | 14 | Active |
| US10780151B2 | Composition and therapeutic anti-tumour vaccine | Human Necessities | 3 | Active |
| US9580739B2 | Test for predicting neutralization of asparaginase activity | Physics | 3 | Active |
| US9968663B2 | Erythrocytes containing arginine deiminase | Emerging Cross-Sectional Technologies | 2 | Active |
| US10046009B2 | Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor | Human Necessities | 2 | Active |
| US10273444B2 | Lysis/resealing process and device for incorporating an active ingredient, in particular asparaginase or inositol hexaphosphate, in erythrocytes | Human Necessities | 1 | Active |
| US11141468B2 | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | Chemistry; Metallurgy | 1 | Active |
| US10286008B2 | Method for stabilising suspensions of red blood cells encapsulating an active ingredient | Human Necessities | 1 | Active |
| US10780126B2 | Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor | Human Necessities | 1 | Active |
| US11458170B2 | Pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor | Human Necessities | 0 | Active |
| US11273210B2 | Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency | Chemistry; Metallurgy | 0 | Active |
| US11957724B2 | Phage therapy of E coli infections | Emerging Cross-Sectional Technologies | 0 | Active |
| US12280080B2 | Antibacterial composition and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.